BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 195 filers reported holding BEAM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $232,098 | -55.9% | 9,906 | -37.8% | 0.03% | -50.7% |
| Q1 2024 | $525,964 | +99.9% | 15,919 | +64.7% | 0.07% | +31.4% |
| Q4 2023 | $263,136 | +381.6% | 9,667 | +325.5% | 0.05% | +218.8% |
| Q3 2023 | $54,642 | +38.6% | 2,272 | +84.0% | 0.02% | +33.3% |
| Q2 2023 | $39,434 | +5.8% | 1,235 | +1.5% | 0.01% | -7.7% |
| Q1 2023 | $37,265 | +0.1% | 1,217 | +27.8% | 0.01% | -13.3% |
| Q4 2022 | $37,233 | -13.4% | 952 | +6.4% | 0.02% | -16.7% |
| Q3 2022 | $43,000 | – | 895 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,346,934 | $56,443,763 | 54.70% |
| HSG Holding Ltd | 796,089 | $19,145,940 | 2.05% |
| Redmile Group, LLC | 1,469,725 | $35,346,886 | 1.68% |
| ARK Investment Management | 8,783,891 | $211,252,590 | 1.62% |
| Casdin Capital, LLC | 570,000 | $13,708,500 | 1.52% |
| Deep Track Capital, LP | 1,015,641 | $24,426,166 | 0.94% |
| Yiheng Capital Management, L.P. | 560,500 | $13,480,025 | 0.69% |
| Temasek Holdings (Private) Ltd | 4,317,789 | $103,842,825 | 0.62% |
| FARALLON CAPITAL MANAGEMENT LLC | 4,481,839 | $107,788,228 | 0.50% |
| Alphabet Inc. | 321,604 | $7,734,576 | 0.50% |